Location · San Francisco, CA
Clinical trials in San Francisco, CA
681 recruiting studies have a site in the San Francisco area, and 249 of them accept healthy volunteers. The area includes Oakland, Berkeley, San Mateo, Palo Alto, Stanford, Redwood City and nearby cities.
681 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Fate Therapeutics
- Location
- Beverly Hills, CA + 15 other US sites
- Eligibility basics
- Ages 12–70
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- California City, CA + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc.
- Location
- La Jolla, CA + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- San Francisco, CA + 6 other US sites
- Eligibility basics
- Ages 6–11
- Recruiting
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Enterra Medical, Inc.
- Location
- Scottsdale, AZ + 11 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
NT-II™ Collagen for Joint Discomfort and Function
Hofseth Biocare ASA
- Location
- San Francisco, CA
- Eligibility basics
- Ages 20–65
- RecruitingPhase 3
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Takeda
- Location
- Birmingham, AL + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Assess Anktiva in Patients With Long Covid-19.
ImmunityBio, Inc.
- Location
- San Francisco, CA
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Imaging Immune Activation in COVID-19
CellSight Technologies, Inc.
- Location
- San Francisco, CA
- Eligibility basics
- Ages 18+
- Recruiting
J-Valve Transfemoral Pivotal Study
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Location
- Scottsdale, AZ + 33 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda
- Location
- La Jolla, CA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 1/Phase 2
A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)
Aspa Therapeutics
- Location
- Oakland, CA + 2 other US sites
- Eligibility basics
- Up to age 2
- Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Cardiac Dimensions, Inc.
- Location
- Gilbert, AZ + 50 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
i-SENS, Inc.
- Location
- Walnut Creek, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Op-T LLC
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Ages 18–50
- RecruitingPhase 2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
BioMarin Pharmaceutical
- Location
- Phoenix, AZ + 6 other US sites
- Eligibility basics
- Ages 0 mo–3
- RecruitingPhase 2
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
RECORDATI GROUP
- Location
- San Francisco, CA + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Tucson, AZ + 36 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Biomed Industries, Inc.
- Location
- Phoenix, AZ + 13 other US sites
- Eligibility basics
- Ages 5–20 · Women only
- RecruitingPhase 1/Phase 2
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
ModernaTX, Inc.
- Location
- Palo Alto, CA + 5 other US sites
- Eligibility basics
- Ages 1+
- RecruitingPhase 1/Phase 2
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Tenaya Therapeutics
- Location
- La Jolla, CA + 4 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
XVIVO Perfusion
- Location
- La Jolla, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Takeda
- Location
- Birmingham, AL + 18 other US sites
- Eligibility basics
- Ages 16–70